Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
Standard
Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms. / Kämpf, Philipp; Agelink, M W; Naber, Dieter.
in: PHARMACOPSYCHIATRY, Jahrgang 38, Nr. 1, 1, 2005, S. 39-40.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Kämpf, P, Agelink, MW & Naber, D 2005, 'Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.', PHARMACOPSYCHIATRY, Jg. 38, Nr. 1, 1, S. 39-40. <http://www.ncbi.nlm.nih.gov/pubmed/15706467?dopt=Citation>
APA
Kämpf, P., Agelink, M. W., & Naber, D. (2005). Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms. PHARMACOPSYCHIATRY, 38(1), 39-40. [1]. http://www.ncbi.nlm.nih.gov/pubmed/15706467?dopt=Citation
Vancouver
Kämpf P, Agelink MW, Naber D. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms. PHARMACOPSYCHIATRY. 2005;38(1):39-40. 1.
Bibtex
@article{216e9789592248879028227a0183a304,
title = "Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.",
author = "Philipp K{\"a}mpf and Agelink, {M W} and Dieter Naber",
year = "2005",
language = "Deutsch",
volume = "38",
pages = "39--40",
journal = "PHARMACOPSYCHIATRY",
issn = "0176-3679",
publisher = "Georg Thieme Verlag KG",
number = "1",
}
RIS
TY - JOUR
T1 - Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
AU - Kämpf, Philipp
AU - Agelink, M W
AU - Naber, Dieter
PY - 2005
Y1 - 2005
M3 - SCORING: Zeitschriftenaufsatz
VL - 38
SP - 39
EP - 40
JO - PHARMACOPSYCHIATRY
JF - PHARMACOPSYCHIATRY
SN - 0176-3679
IS - 1
M1 - 1
ER -
